Clinical Trial Update: Study to Evaluate the Preliminary Efficacy of SKB264 and the Effect of Clarithromycin on the PK of SKB264 in OC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating preliminary efficacy of SKB264 and the effect of clarithromycin on SKB264 pharmacokinetics in ovarian epithelial cancer (NOT_Y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Epithelial Cancer

Drugs mentioned

• SKB264
• clarithromycin (clarithromycin)

Snippet

Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Conditions: Ovarian Epithelial Cancer | Phase 2 | Status: NOT_YET_RECRUITING